Antitumoral activity of new polyamine-naphthoquinone conjugates

Oncology Reports

Volumn 20, Issue 1, 2008, Pages 225-231

  Esteves Souza, Andressa ^a   Araújo Lúcio, Kelly ^a   da Cunha, Andréa Sousa ^a   da Cunha Pinto, Angelo ^a   da Silva Lima, Edson Luiz ^a   Camara, Celso Amorim ^b   Domingues Vargas, Maria ^c   Gattass, Cerli Rocha ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

1,4 naphthoquinone; Anti tumoral activity; Apoptosis; Cytotoxic activity; Spermidine naphthoquinone conjugate

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CISPLATIN; LAPACHOL; LAWSONE; NATURAL PRODUCT; POLYAMINE DERIVATIVE; QUERCETIN; REACTIVE OXYGEN METABOLITE; SPERMIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; NAPHTHOQUINONE; POLYAMINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CELL CYCLE G1 PHASE; CELL DEATH; CELL LINE; CELL STRAIN HL 60; CELL VIABILITY; COLORIMETRY; CONCENTRATION RESPONSE; CYTOTOXICITY; DAUDI CELL; DNA FRAGMENTATION; DRUG CONJUGATION; DRUG EXPOSURE; DRUG STRUCTURE; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; HUMAN; HUMAN CELL; IC 50; LINEAR REGRESSION ANALYSIS; LUNG CANCER; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; TUMOR CELL LINE; ANIMAL; DRUG EFFECT; METABOLISM;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DNA FRAGMENTATION; HUMANS; MICE; NAPHTHOQUINONES; POLYAMINES; REACTIVE OXYGEN SPECIES;

EID: 49849090349     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.20.1.225     Document Type: Article

References (30)

1. Horn Y, Beai SL, Walach N, Lubich WP, Spigel L and Marton LJ: Further evidence for the use of polyamines as biochemical markers for malignant tumors. Cancer Res 42: 3248-3251, 1982.
2. Pegg AE and McCann PP: Polyamine metabolism and function. Am J Physiol 243: 212-221, 1982.
3. Tabor CW and Tabor H: Polyamines. Ann Rev Biochem 53: 749-790, 1984.
4. Casero RA Jr and Woster PM: Terminally alkylated polyamine analogues as chemotherapeutic agents. J Med Chem 44: 1-26, 2001.
5. Seiler N: Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Curr Drug Targets 4: 537-564, 2003.
6. Seiler N: Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Curr Drug Targets 4: 565-585, 2003.
7. Seiler N: Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapy. Pharmacol Ther 107: 99-119, 2005.
8. Delcros JG, Tomasi S, Carrington S, Martin B, Renault J, Blagbrough IS and Uriac P: Effect of spermine conjugation on the cytotoxicity and cellular transport of acridine. J Med Chem 45: 5098-5111, 2002.
9. Holley JL, Mather A, Wheelhouse RT, Cullis PM, Hartley JA, Bingham JP and Cohen GM: Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugate. Cancer Res 52: 4190-4195, 1992.
10. Rao KV, McBride TJ and Oleson JJ: Recognition and evaluation of lapachol as an antitumor agent. J Cancer Res 28: 1952-1954, 1968.
11. Linardi MCF, Oliveira MM and Sampaio MRP: Lapachol derivative active against mouse lymphocytic leukemia P-388. J Med Chem 18: 1159-1161, 1975.
12. Ueda S, Umemura T, Dohguchi K, Matsuzaki T, Tokuda H, Nishino H and Iwashima A: Production of anti-tumour-promoting furanonaphthoquinones in Tabebuia avellanedae cell cultures. Phytochemistry 36: 323-325, 1994.
13. Watanabe N and Forman HJ: Autoxidation of extracellular hydroquinones is a causative event for the cytotoxicity of menadione and DMNQ in A549-S cells. Arch Biochem Biophys 411: 145-157, 2003.
14. Cunha AS, Lima ELS, Pinto AC, Esteves-Souza A, Echevarria A, Camara CA, Vargas MD and Torres JC: Synthesis of novel naphthoquinone-spermidine conjugates and their effects on DNA-topoisomerases I and II-α. J Braz Chem Soc 17: 439-442, 2006.
15. Camara CA, Pinto AC, Rosa MA and Vargas MD: Secondary amines and unexpected 1-aza-anthraquinones from 2-methoxylapachol. Tetrahedron 57: 9569-9574, 2001.
16. Silva TMS, Camara CA, Barbosa TP, Soares AZ, Cunha LC, Pinto AC and Vargas MD: Molluscicidal activity of synthetic lapachol amino and hydrogenated derivatives. Bioorg Med Chem 13: 193-196, 2005.
17. Fieser LF and Martin EL: 2-Hydroxy-1,4-naphthoquinone. Org Synth Coll 3: 465-467, 1995.
18. Silva ET, Cunha AS and Lima ELS: An efficient protocol for solution- and solid-phase end-group differentiation of spermidine. Bioorg Med Chem Lett 12: 3207-3208, 2002.
19. Silva ET, Fona FS and Lima ELS: The use of Fukuyama's sulfonamide in the synthesis of selectively protected spermidines. J Braz Chem Soc 15: 433-436, 2004.
20. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63, 1983.
21. Nicoletti I, Megliorati G, Pagliacci MC, Grignani F and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 139: 271-279, 1991.
22. Sasaki M, Kobayashi D and Watanabe N: Augmented adriamycin sensitivity in cells transduced with an antisense tumor necrosis factor gene is mediated by caspase-3 downstream from reactive oxygen species. Jpn J Cancer Res 92: 983-988, 2001.
23. Guéritte-Voegelein F, Sénilh V, David B, Guénard D and Potier P: Chemical studies of 10-deacetyl baccatin III. Hemisynthesis of taxol derivatives. Tetrahedron 42: 4451-4460, 1986.
24. Bissery MC, Nohynek G, Sanderink GJ and Lavelle F: Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: preclinical experience. Anti-Cancer Drugs 6: 339-368, 1995.
25. Esteves-Souza A, Figueiredo DV, Esteves A, Camara CA, Vargas MD, Pinto AC and Echevarria A: Cytotoxic and DNA-topoisomerase effects of lapachol amine derivatives and inter-actions with DNA. Braz J Med Biol Res 40: 1399-1402, 2007.
26. Lin CH, Huang CC, Wang TW, Wang YJ and Lin PH: Disparity in the induction of glutathione depletion, ROS formation, poly(ADP-ribose) polymerase-1 activation, and apoptosis by quinonoid derivatives of naphthalene in human cultured cells. Chem Biol Interact 165: 200-210, 2007.
27. Ott M, Zhivotovsky B and Orrenius S: Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Diff 14: 1243-1247, 2007.
28. Del Corral JMM, Castro MA, Gordaliza M, Martín ML, Gamito AM, Cuevas C and Feliciano AS: Synthesis and cytotoxicity of new heterocyclic terpenylnaphthoquinones. Bioorg Med Chem 14: 2816-2827, 2006.
29. Silva AJM, Buarque CD, Brito FV, Aurelian L, Macedo LF, Malkas LH, Hickey RJ, Lopes DVS, Noël F, Murakami YLB, Silva NMV, Melo PA, Caruso RRB, Castro NG and Costa PRR: Synthesis and preliminary pharmacological evaluation of new (±) 1,4-naphthoquinones structurally related to lapachol. Bioorg Med Chem 10: 2731-2738, 2002.
30. Kongkathip N, Kongkathip B, Siripong PB, Sangma CN, Luangkamin S, Niyomdecha M, Pattanapa S, Piyaviriyagulb S and Kongsaereec P: Potent antitumor activity of synthetic 1,2-naphthoquinones and 1,4-naphthoquinones. Bioorg Med Chem 11: 3179-3191, 2003.